UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 161 filers reported holding UNIQURE NV in Q3 2019. The put-call ratio across all filers is 0.13 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,037,000 | -86.5% | 50,000 | -79.1% | 0.06% | -80.1% |
| Q3 2021 | $7,668,000 | +3.9% | 239,548 | 0.0% | 0.31% | +24.3% |
| Q2 2021 | $7,378,000 | -12.4% | 239,548 | -4.2% | 0.25% | +33.5% |
| Q1 2021 | $8,422,000 | -6.8% | 250,000 | 0.0% | 0.19% | -12.6% |
| Q4 2020 | $9,032,000 | -24.5% | 250,000 | -23.1% | 0.22% | -53.3% |
| Q3 2020 | $11,970,000 | -40.2% | 325,000 | -26.8% | 0.46% | -39.8% |
| Q2 2020 | $20,014,000 | +68.7% | 444,157 | +77.7% | 0.76% | +38.7% |
| Q1 2020 | $11,863,000 | -58.6% | 250,000 | -37.5% | 0.55% | -51.8% |
| Q4 2019 | $28,664,000 | -19.1% | 400,000 | -55.6% | 1.14% | -46.9% |
| Q3 2019 | $35,424,000 | -35.2% | 900,000 | +28.6% | 2.16% | -31.4% |
| Q2 2019 | $54,705,000 | – | 700,000 | – | 3.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 841,471 | $15,786,000 | 5.69% |
| Nantahala Capital Management | 2,901,929 | $54,440,000 | 3.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 544,500 | $10,209,000 | 3.27% |
| 683 Capital Management, LLC | 1,373,600 | $25,768,000 | 1.99% |
| PFM Health Sciences, LP | 2,393,311 | $44,899,000 | 1.62% |
| Integral Health Asset Management, LLC | 433,000 | $8,123,000 | 1.58% |
| Privium Fund Management B.V. | 238,998 | $4,283,000 | 1.56% |
| Nantahala Capital Management | 1,000,000 | $18,760,000 | 1.21% |
| Henry James International Management Inc. | 89,469 | $1,678,000 | 0.94% |
| Altium Capital Management LP | 105,000 | $1,970,000 | 0.72% |